XML 115 R95.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Employee Compensation - Summary of Stock Option Activity (Details) - Stock Option [Member] - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
LVSC 2004 Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 13,264,517    
Granted (in shares) 1,730,000 4,513,468 875,474
Forfeited or expired (in shares) (455,743)    
Outstanding, ending balance (in shares) 14,538,774 13,264,517  
Exercisable as of the end of the period (in shares) 8,058,372    
Outstanding, beginning balance, weighted average exercise price (in usd per share) $ 49.35    
Granted, weighted average exercise price (in usd per share) 41.61    
Forfeited or expired, weighted average exercise price (in usd per share) 60.19    
Outstanding, ending balance, weighted average exercise price (in usd per share) 48.09 $ 49.35  
Exercisable as of the end of the period, weighted average exercise price (in usd per share) $ 53.65    
Outstanding, weighted average remaining contractual life (in years) 6 years 5 months 12 days    
Exercisable, weighted average remaining contractual life (in years) 5 years 10 days    
Outstanding, aggregate intrinsic value $ 74    
Exercisable, aggregate intrinsic value $ 21    
SCL Equity Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 48,180,300    
Granted (in shares) 3,300,000 0 0
Forfeited or expired (in shares) (3,079,400)    
Outstanding, ending balance (in shares) 48,400,900 48,180,300  
Exercisable as of the end of the period (in shares) 41,687,600    
Outstanding, beginning balance, weighted average exercise price (in usd per share) $ 5.01    
Granted, weighted average exercise price (in usd per share) 2.28    
Forfeited or expired, weighted average exercise price (in usd per share) 4.69    
Outstanding, ending balance, weighted average exercise price (in usd per share) 4.84 $ 5.01  
Exercisable as of the end of the period, weighted average exercise price (in usd per share) $ 5.02    
Outstanding, weighted average remaining contractual life (in years) 4 years 11 months 12 days    
Exercisable, weighted average remaining contractual life (in years) 4 years 5 months 19 days    
Outstanding, aggregate intrinsic value $ 3    
Exercisable, aggregate intrinsic value $ 0